Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
When your budget is failing, prioritize essential expenses, cut non-essentials, and reallocate funds. This guide offers practical steps to regain control.
16,732 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Molson Coors shares fell sharply after a disappointing quarter and a formal downgrade from a major bank. This article...
The bwlp 2025 earnings call is a pivotal moment for BW LPG investors. This article breaks down what to expect, how to...
Tech names surged as AI infrastructure demand strengthens revenue outlook. This article breaks down what happened, wh...
BioNTech’s stock is under pressure as investors react to weak guidance and leadership pivots. This deep dive breaks d...
Florida once drew nonstop investor attention. A survey from Redfin says that momentum is cooling, reshaping how buyer...
Geopolitics could hit the showroom floor. This article explains how the iran conflict could capsize auto sales, which...
The AI boom has turned Nvidia and AMD into poster children for opportunity—and risk. This guide breaks down the signa...
Beaten-down stocks often hide big upside. Explore a practical, evidence-based approach to identifying a candidate tha...
Apyx Medical (APYX) 2026 is shaping up as a pivotal year for investors. This guide breaks down how to read the Q1 tra...
Praxis (Prax) 2026 earnings signals a path from solid growth to stronger profitability. This analysis breaks down the...
As market volatility persists in 2026, retirees with a $100K variable annuity inside an IRA confront a key choice: ta...